Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients

Author： Takahashi Nobunori   Kojima Toshihisa   Terabe Kenya   Kaneko Atsushi   Kida Daihei   Hirano Yuji   Fujibayashi Takayoshi   Yabe Yuichiro   Takagi Hideki   Oguchi Takeshi   Miyake Hiroyuki   Kato Takefumi   Fukaya Naoki   Ishikawa Hisato   Hayashi Masatoshi   Tsuboi Seiji   Kato Daizo   Funahashi Koji   Matsubara Hiroyuki   Hattori Yosuke   Hanabayashi Masahiro   Hirabara Shinya   Yoshioka Yutaka   Ishiguro Naoki  

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.23, Iss.5, 2013-09, pp. : 904-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

By Takeuchi Tsutomu  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 226-235

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

By Takeuchi Tsutomu  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 236-236

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial

By Christensen Robin   Tarp Simon   Furst Daniel E   Kristensen Lars E   Bliddal Henning  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 6, 2013-12 ,pp. : 647-655

Future Medicine

Access to resources Recommend Favorite

Durability of therapeutic response in rheumatoid arthritis: clinical trial experience with abatacept

By Shergy William  

Future Rheumatology, Vol. 3, Iss. 6, 2008-12 ,pp. : 507-516

Future Medicine

Access to resources Recommend Favorite

Clinical significance of anti‐citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis

By Nakamura H.   Kawakami A.   Ida H.   Origuchi T.   Matsuoka N.   Tsuboi M.   Furuyama M.   Mizokami A.   Tsukada T.   Nakashima M.   Ejima E.   Hamasaki K.   Aoyagi K.   Uetani M.   Fukuda T.   Honda S.   Urayama S.   Kawabe Y.   Ueki Y.   Mine M.   Eguchi K.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 489-490

Informa Healthcare

Access to resources Recommend Favorite